Pearl Tan

Pearl joined Proteomics International in 2013, and is now responsible for managing the product development and commercialisation of PromarkerD, the company’s predictive diagnostic test for diabetic kidney disease.

Pearl has a background in Research, focusing on Biochemistry and Molecular Biology. She dedicated her career to the biotechnology industry following her involvement in an Industry-Research Collaboration (Researchers in Business Grant) between Proteomics International and UWA, to commercialise a patented technology for measuring oxidative stress.